Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study

Area of Science:

• Genetics and Epidemiology
• Cancer Research
• Molecular Biology

Background:

• Glutathione S-transferases (GSTs) are crucial for detoxifying carcinogens.
• Null genotypes of GSTM1 and GSTT1 may impair carcinogen metabolism, potentially increasing cancer risk.
• Bladder cancer etiology involves genetic susceptibility and environmental factors.

Purpose of the Study:

• To investigate if GSTM1 and GSTT1 null genotypes are risk factors for bladder cancer.
• To determine the association between these genotypes and bladder cancer severity (grade and stage).

Main Methods:

• A case-control study involving 89 bladder cancer patients and 147 controls from Northwestern Greece.
• Genotyping for GSTM1 and GSTT1 null variants performed using multiplex polymerase chain reaction on DNA from peripheral blood.
• Statistical analysis using the chi-squared test to compare genotype frequencies and assess associations with tumor grade and stage.

Main Results:

• A significant association was found between the GSTM1 null genotype and an increased risk of bladder cancer (Odds Ratio = 2.76).
• The GSTM1 null genotype showed a non-significant correlation with advanced disease stage (Odds Ratio = 2.6 for invasive disease).
• No statistically significant association was observed between the GSTM1 null genotype and tumor grade, nor between the GSTT1 null genotype and bladder cancer risk or severity.

Conclusions:

• The GSTM1 null genotype is a significant risk factor for bladder cancer development.
• While not associated with higher tumor grade, the GSTM1 null genotype correlates with increased disease stage in bladder cancer patients.
• The GSTT1 null genotype does not appear to be associated with bladder cancer risk or severity in this population.